✦ LIBER ✦

Glycoprotein IIb/IIIa blockade improves endothelial dysfunction in CAD

Book ID: 120858279
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2003
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200314050-00046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet glycoprotein IIb/IIIa receptor

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

✍ A.Michael Lincoff; Robert M Califf; Eric J Topol 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 330 KB

Platelet glycoprotein IIb/IIIa receptor

Platelet glycoprotein IIb/IIIa receptor blockade and coronary resistance in unstable angina

✍ Mario Marzilli; Gianmario Sambuceti; Roberto Testa; Silvio Fedele 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Coronary stenting and platelet glycoprot

Coronary stenting and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction

✍ Giovanni M. Santoro; Leonardo Bolognese 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Platelet Glycoprotein IIb/IIIa Integrin

Platelet Glycoprotein IIb/IIIa Integrin Blockade in Coronary Artery Disease: Current State of the Art

✍ Huay-Cheem Tan; Robert A. Harrington; James E. Tcheng 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 277 KB

P15 IL-6 blockade improves endothelial d

P15 IL-6 blockade improves endothelial dysfunction in rheumatoid arthritis

✍ Ashit Syngle; J Kaur; P Krishan; K Vohra; M Chhabra; R Malik; L Kaur; M Kaur 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Platelet glycoprotein IIb/IIIa receptor

Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease

✍ Etheridge, Susan P. ;Tani, Lloyd Y. ;Minich, L. LuAnn ;Revenaugh, James R. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB

A 4-month-old girl with Kawasaki disease, large coronary artery aneurysms, and coronary thrombi was treated with standard therapy followed by abciximab, a platelet glycoprotein IIb/IIIa antagonist, in addition to standard heparin and warfarin sodium anticoagulation and low-dose aspirin. She did not